ClinicalTrials.gg
Status unknownNCT04386200Updated May 15, 2020

Web-based Approach in Nutrition and Diabetes

An interventional study of web-based thecnologies and traditional approach in Type 2 Diabetes Mellitus, Overweight and Obesity and Nutritional and Metabolic Diseases, sponsored by Università degli Studi 'G. d'Annunzio' Chieti e Pescara. Status unknown at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-05-15.

Sponsored by Università degli Studi 'G. d'Annunzio' Chieti e Pescara · Not applicable, Interventional, and Prevention

How we know

The sponsor has not verified this record recently (last verified May 2020), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Feb 2019, registered May 2020).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 421 studies in Diabetes Mellitus, Type 2 with a site in Italy — 45 open to participants now, 61 under way, 12 of them phase 3. Diabetes Mellitus, Type 2 · Italy.

Planned enrollment
282nd of 321
40 · median 320
Started
2019
with 19 others
No phase
71 of 421
14 open now
Registered
295th of 421
by date

Among the 421 studies in Diabetes Mellitus, Type 2 with a site in Italy, this one is the 282nd largest by planned enrollment of the 321 interventional ones that give a count, is one of 20 that started in 2019, is one of 71 with no phase, and was the 295th registered.

Diabetes Mellitus, Type 2

10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

45 of the 421 studies in Diabetes Mellitus, Type 2 with a site in Italy are open now. Recruiting first, the newest first:

40 more — sign in →

All 45 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 421 studies in Diabetes Mellitus, Type 2 with a site in Italy, or all of them as a file.
02

Study summary

The study aims to test web-based strategies, in overweight or obese participants at risk or affected by Type 2 Diabetes Mellitus , to promote adherence over time to a healthy lifestyle and nutritional medical therapy (TMN). The study population includes 40 subjects, randomly allocated to web group (therapeutic reinforcement through web-based strategies) or traditional group (traditional educational approach). Anthropometric and clinical parameters will be collected, as well as scores of validated questionnaires will be administered up to 12 months from the enrollment.

03

Conditions studied

  • Type 2 Diabetes Mellitus
  • Overweight and Obesity
  • Nutritional and Metabolic Diseases

Keywords

  • Web technologies
  • Nutrition
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Overweight or obesity ( ≥25 kg/m2)
  • Participants with or at risk of Type 2 Diabetes Mellitus
  • Skills in the use web-based technologies and internet accessibility

Exclusion criteria

Exclusion Criteria:

  • Conditions that could interfere with the execution and completion of the project or failure adherence to the protocol.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    WEB GROUP

    Traditional approach integrated with web-based technologies.

    Other: web-based thecnologies

  • Other
    TRADITIONAL GROUP

    Traditional educational approach

    Behavioral: traditional approach

Interventions

  • Otherweb-based thecnologies

    Integration of "traditional" face-to-face educational approach with web-based technologies.

  • Behavioraltraditional approach

    "traditional" face-to-face educational approach

06

What researchers measure

Primary outcomes

  1. Change from baseline in Body Weight

    Assessment of body weight (in kilograms) at baseline and after 3, 6, 9 and 12 months

    Time frame: Baseline, month 3, month 6, month 9 and month12

Secondary outcomes

  1. Change from baseline in BMI

    Assessment of BMI (kg/m\^2) at baseline and after 3, 6, 9 and 12 months

    Time frame: Baseline, month 3, month 6, month 9 and month12

  2. Change from baseline in body circumferences

    Assessment of body circumferences (in centimeters) at baseline and after 3, 6, 9 and 12 months

    Time frame: Baseline, month 3, month 6, month 9 and month12

  3. Change from baseline in Systolic and Diastolic blood pressure

    Assessment of Systolic and Diastolic blood pressure (mm hg) at baseline and after 3, 6, 9 and 12 months

    Time frame: Baseline, month 3, month 6, month 9 and month12

  4. Change from baseline in fasting blood glucose

    Assessment of fasting blood glucose (mg/dl) at baseline and after 3, 6, 9 and 12 months

    Time frame: Baseline, month 3, month 6, month 9 and month12

  5. Change from baseline in HbA1C

    Assessment of HbA1C at baseline and after 3, 6, 9 and 12 months

    Time frame: Baseline, month 3, month 6, month 9 and month12

  6. Change from baseline in Dietary habits estimated by PREvencion con DIetaMEDiterranea questionnaire (PREDIMED questionnaire)

    Assessment of Dietary habits at baseline and after 3, 6, 9 and 12 months. Changes in dietary habits will be estimated using a 14-item PREDIMED questionnaire which is a questionnaire to assess the adherence to the Mediterranean diet, 0 being the minimum total score and 14 the maximum total score. Higher values represent a higher adherence to the Mediterranean diet.

    Time frame: Baseline, month 3, month 6, month 9 and month12

  7. Change from baseline in physical activity level estimated by the International Physical Activity Questionnaire (IPAQ) - short form

    Assessment of physical activity level at baseline and after 3, 6, 9 and 12 months. Changes in the level of physical exercise will be estimated by the International Physical Activity Questionnaire (IPAQ-short form) which is a questionnaire to assess the level of physical activity. Patients are asked to measure the average amount of time spent in sedentary behaviours and different intensity levels of physical activity. The questionnaire obtains three different intensity levels of physical activity: low, moderate and high.

    Time frame: Baseline, month 3, month 6, month 9 and month12

  8. Change from baseline in Quality of life by 36-item short form health survey (SF-36)

    Assessment of Quality of life by SF-36 at baseline and after 3, 6, 9 and 12 months. The 36-Item Short Form Health Survey (SF-36) is a self-report generic quality of life measure. The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) with scores ranging from 0 to 100. Higher scores indicate greater self-reported quality of life.

    Time frame: Baseline, month 3, month 6, month 9 and month12

07

Study locations

1 site
  • Hospital "SS Annunziata"
    Chieti, 66100, Italy
08

References and documents

Publications

  • Fraticelli F, Nicola MD, Vitacolonna E. A nutritional web-based approach in obesity and diabetes before and during the COVID-19 lockdown. J Telemed Telecare. 2023 Feb;29(2):91-102. doi: 10.1177/1357633X20966933. Epub 2020 Oct 21. PubMed 33081596 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2019 (actual). Primary completion is estimated for Oct 2020, 20 months after the start.

Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 20 months is close to that.

Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
May 5, 2020
First posted
May 13, 2020
StartActual
Feb 13, 2019
Primary completionEst.
Oct 2020
CompletionEst.
Oct 2020
Last update
May 15, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 15, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04386200
Lead sponsor
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Responsible party
Ester Vitacolonna (Professor, Università degli Studi 'G. d'Annunzio' Chieti e Pescara) — Principal investigator
First posted
May 13, 2020
Start date
Feb 13, 2019
Primary completion
Oct 2020 (estimated)
Completion
Oct 2020 (estimated)
Last update
May 15, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion